First Comprehensive Analysis of Full-Length and Δ2 Foxp3 Isoforms Distribution in PBMCs from Healthy Volunteers
Biomolecules · 25.06.2026 · 16 (7) · 948
DOI: 10.3390/biom16070948 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 25.06.2026. Verfasst von Manuel Fernández-Delgado und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service of Hematology and Hemotherapy, Hospital General Universitario de Castellón, 12004 Castelló de la Plana, Spain. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Leukocytes, Mononuclear. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
FOXP3 is the master transcriptional regulator of regulatory T cells (Tregs) and is expressed in humans as two main alternatively spliced isoforms: full-length FOXP3 (FOXP3-FL) and the exon 2-deficient variant (FOXP3-Δ2). While the role of these isoforms has been mainly studied in CD4+ T cells, their distribution across peripheral blood leukocyte populations and their relationship with immune checkpoint expression remain incompletely defined. In this study, we used a multiparametric flow cytometry panel allowing isoform-specific detection of FOXP3-FL and FOXP3-Δ2, together with PD-1 and CTLA-4, to analyze peripheral blood samples from six healthy donors under basal conditions. Major leukocyte populations, including CD4+CD25+ and CD4+CD25− T cells, CD8+ T cells, monocytes, and neutrophils, were evaluated. FOXP3-FL predominated in CD4+CD25+ T cells, whereas FOXP3-Δ2 was more frequently detected in CD8+ T cells, monocytes, and neutrophils. However, the absolute frequencies of these FOXP3-Δ2-positive populations were low, consistent with the overall low levels of FOXP3 expression observed in these cell types. In CD4+ T-cell subsets, PD-1 expression was generally higher than CTLA-4, regardless of FOXP3 isoform, and FOXP3-Δ2+ cells showed relatively higher PD-1 expression compared to FOXP3-FL+ cells. In contrast, checkpoint expression in non-CD4+ populations was limited. The observed FOXP3-FL+/FOXP3-Δ2+ ratios across immune cell populations were consistent with a predominant role of FOXP3-FL in maintaining immune tolerance under basal conditions; whether these patterns are preserved or altered in pathological settings warrants further investigation. These results provide a descriptive overview of FOXP3 isoform distribution and checkpoint expression across peripheral blood immune cell subsets in healthy individuals, which may serve as a reference for future studies in immune-mediated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service of Hematology and Hemotherapy, Hospital General Universitario de Castellón, 12004 Castelló de la Plana, Spain.
- Gene Therapy and Pharmacogenomics, Department of Pharmacology, Universitat de València, 46010 Valencia, Spain.
- Unit of Pharmacogenetics and Gene Therapy, La Fe Health Research Institute, 46026 Valencia, Spain.
ORCID-Profile: Manuel Fernández-Delgado, Luis Sendra, María José Herrero, Gladys G Olivera-Pasquini, Enrique G Zucchet, Salvador F Aliño
Zitieren
APA
Fernández-Delgado, M., Sendra, L., Herrero, M. J., Olivera-Pasquini, G. G., Zucchet, E. G., García-Boyero, R., & Aliño, S. F. (2026). First Comprehensive Analysis of Full-Length and Δ2 Foxp3 Isoforms Distribution in PBMCs from Healthy Volunteers. Biomolecules, 16(7), 948. https://doi.org/10.3390/biom16070948
Vancouver
Fernández-Delgado M, Sendra L, Herrero MJ, Olivera-Pasquini GG, Zucchet EG, García-Boyero R, et al. First Comprehensive Analysis of Full-Length and Δ2 Foxp3 Isoforms Distribution in PBMCs from Healthy Volunteers. Biomolecules. 2026;16(7):948. doi:10.3390/biom16070948
BibTeX
@article{FernndezDelgado2026,
author = {Fernández-Delgado, Manuel and Sendra, Luis and Herrero, María José and Olivera-Pasquini, Gladys G and Zucchet, Enrique G and García-Boyero, Raimundo and Aliño, Salvador F},
title = {First Comprehensive Analysis of Full-Length and Δ2 Foxp3 Isoforms Distribution in PBMCs from Healthy Volunteers},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {948},
doi = {10.3390/biom16070948}
}
EUVIMED